Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?

被引：0
|
作者：
Leonard B Saltz
机构：
[1] Attending Physician and Member,
[2] Memorial Sloan-Kettering Cancer Center,undefined
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：20 / 21
页数：1
相关论文
共 50 条
  • [1] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Rosati, G
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (01): : 20 - 21
  • [2] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Saltz, LB
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 20 - 21
  • [3] Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
    Gerardo Rosati
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 20 - 21
  • [4] Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
    Van Cutsem, Eric
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 72 - 73
  • [5] Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
    Eric Van Cutsem
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 72 - 73
  • [6] Cetuximab and irinotecan in patients with colorectal cancer refractory to oxaliplatin and irinotecan
    Gonzalez-Baron, M.
    Blanco, M.
    Feliu, J.
    Gomez, C.
    Casado, E.
    Castro, J.
    Belda-Iniesta, C.
    Garrido, M.
    Aguayo, C.
    Campos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    Cunningham, D
    Humblet, Y
    Siena, S
    Khayat, D
    Bleiberg, H
    Santoro, A
    Bets, D
    Mueser, M
    Harstrick, A
    Verslype, C
    Chau, I
    Van Cutsem, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04): : 337 - 345
  • [8] Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer
    Larsen, Finn Ole
    Pfeiffer, Per
    Nielsen, Dorte
    Skougaard, Kristin
    Qvortrup, Camilla
    Vistisen, Kirsten
    Fromm, Anne-Lene
    Jorgensen, Trine L.
    Bjerregaard, Jon K.
    Hoegdall, Estrid
    Jensen, Benny V.
    ACTA ONCOLOGICA, 2011, 50 (04) : 574 - 577
  • [9] Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer
    Qvortrup, Camilla
    Jensen, Benny Vittrup
    Jorgensen, Trine Lembrecht
    Nielsen, Dorte
    Bjerregaard, Jon Kroll
    Pfeiffer, Per
    ACTA ONCOLOGICA, 2010, 49 (06) : 833 - 836
  • [10] Cetuximab plus irinotecan in refractory colorectal cancer patients
    Delgao, Marian Gil
    Spano, Jean-Philippe
    Khayat, David
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 407 - 413
12345